Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: A systematic review

被引:44
|
作者
Moossdorff-Steinhauser, Heidi F. A. [1 ]
Berghmans, Bary [2 ]
机构
[1] Fysio Papendrecht, NL-3350 AC Papendrecht, Netherlands
[2] Maastricht Univ, Med Ctr, Pelv Care Ctr Maastricht, Maastricht, Netherlands
关键词
electric stimulation; neuromodulation; overactive; review; tibial nerve; urgency; urinary incontinence; URINARY-TRACT SYMPTOMS; PELVIC ORGAN PROLAPSE; QUALITY-OF-LIFE; DETRUSOR OVERACTIVITY; RISK-FACTORS; PERIPHERAL NEUROMODULATION; ELECTRICAL-STIMULATION; VOIDING DYSFUNCTION; DOUBLE-BLIND; INCONTINENCE;
D O I
10.1002/nau.22296
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims To assess the effectiveness of percutaneous tibial nerve stimulation (PTNS) on adult patients with overactive bladder syndrome, using a systematic review of randomized controlled trials (RCTs), clinical controlled trials (CCTs), and prospective observational cohort studies. Methods A computer-aided literature search was performed in: PubMed, EMBASE and CENTRAL (2000 to November 15, 2011) to identify RCTs, CCTs, and prospective observational cohort studies. The study had to investigate the effect of PTNS on overactive bladder syndrome. The methodological quality of each study was assessed and a qualitative analysis was performed to establish the levels of evidence. Results Four RCTs and six prospective observational cohort studies were identified. There is strong evidence for the efficacy of PTNS versus a sham treatment. There is limited evidence that the use of PTNS and tolterodine ER is equally effective. No additional effect of a combination of Stoller afferent nerve stimulation (SANS) and anticholinergic medication compared to SANS alone. Most cohort studies suggested decreased frequency and improvement of incontinence and nocturia. However, the level of evidence was insufficient to make any firm conclusions. Because the total duration of all included trials varied between 6 and 12 weeks, so far there is little information on treatment periods. Conclusions PTNS is efficacious for frequency and urgency urinary incontinence. More high quality studies are needed to improve the level of evidence concerning the efficacy of PTNS with regard to urgency and nocturia, to specify patient selection criteria, optimal treatment modalities and long-term effects as well as the effectiveness in more pragmatic trials. Neurourol. Urodynam. 32: 206214, 2013. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:206 / 214
页数:9
相关论文
共 50 条
  • [31] Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial
    Preyer, Oliver
    Umek, Wolfgang
    Laml, Thomas
    Bjelic-Radisic, Vesna
    Gabriel, Boris
    Mittlboeck, Martina
    Hanzal, Engelbert
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 191 : 51 - 56
  • [32] Transcutaneous Posterior Tibial Nerve Stimulation for Treatment of the Overactive Bladder Syndrome in Multiple Sclerosis: Results of a Multicenter Prospective Study
    de Seze, Marianne
    Raibaut, Patrick
    Gallien, Philippe
    Even-Schneider, Alexia
    Denys, Pierre
    Bonniaud, Veronique
    Game, Xavier
    Amarenco, Gerard
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (03) : 306 - 311
  • [33] Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder
    Tudor, Katarina Ivana
    Seth, Jai H.
    Liechti, Martina D.
    Ochulor, Juliana
    Gonzales, Gwen
    Haslam, Collette
    Fox, Zoe
    Pakzad, Mahreen
    Panicker, Jalesh N.
    CLINICAL AUTONOMIC RESEARCH, 2020, 30 (01) : 61 - 67
  • [34] Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary?
    Van der Pal, F
    Van Balken, MR
    Heesakkers, JPFA
    Debruyne, FMJ
    Bemelmans, BLH
    BJU INTERNATIONAL, 2006, 97 (03) : 547 - 550
  • [35] Factors Associated With Long-Term Use of Percutaneous Tibial Nerve Stimulation for Management of Overactive Bladder Syndrome
    Gordon, Toya
    Merchant, Maqdooda
    Ramm, Olga
    Patel, Minita
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2021, 27 (07): : 444 - 449
  • [36] Tibial nerve transcutaneous stimulation for refractory idiopathic overactive bladder in children and adolescents
    Bouali, O.
    Even, L.
    Mouttalib, S.
    Moscovici, J.
    Galinier, P.
    Game, X.
    PROGRES EN UROLOGIE, 2015, 25 (11): : 665 - 672
  • [37] Long-Term Durability of Percutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder
    MacDiarmid, Scott A.
    Peters, Kenneth M.
    Shobeiri, S. Abbas
    Wooldridge, Leslie S.
    Rovner, Eric S.
    Leong, Fah Che
    Siegel, Steven W.
    Tate, Susan B.
    Feagins, Brian A.
    JOURNAL OF UROLOGY, 2010, 183 (01) : 234 - 240
  • [38] Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis
    Ghavidel-Sardsahra, Amirhossein
    Ghojazadeh, Morteza
    Rahnama'I, Mohammad Sajjad
    Naseri, Amirreza
    Yazdandoost, Shahabodin
    Khezerloo, Taha
    Seyedi-Sahebari, Sepideh
    Hosseinifard, Hossein
    Vahed, Nafiseh
    Mostafaei, Hadi
    Salehi-Pourmehr, Hanieh
    Hajebrahimi, Sakineh
    NEUROUROLOGY AND URODYNAMICS, 2022, 41 (02) : 539 - 551
  • [39] Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial
    Ramirez-Garcia, Ines
    Blanco-Ratto, Laia
    Kauffmann, Stephanie
    Carralero-Martinez, Andrea
    Sanchez, Emilia
    NEUROUROLOGY AND URODYNAMICS, 2019, 38 (01) : 261 - 268
  • [40] Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation
    Sherif, Hammouda
    Khalil, Mostafa
    Omar, Rabea
    CANADIAN JOURNAL OF UROLOGY, 2017, 24 (03) : 8838 - 8846